A number of firms have modified their ratings and price targets on shares of Penumbra (NYSE: PEN) recently:
- 7/31/2024 – Penumbra had its price target lowered by analysts at Piper Sandler from $260.00 to $200.00. They now have an “overweight” rating on the stock.
- 7/31/2024 – Penumbra had its price target lowered by analysts at Robert W. Baird from $231.00 to $180.00. They now have an “outperform” rating on the stock.
- 7/31/2024 – Penumbra had its price target lowered by analysts at Royal Bank of Canada from $289.00 to $205.00. They now have an “outperform” rating on the stock.
- 7/31/2024 – Penumbra was downgraded by analysts at Citigroup Inc. from a “buy” rating to a “neutral” rating. They now have a $178.00 price target on the stock, up previously from $165.00.
- 7/31/2024 – Penumbra had its “hold” rating reaffirmed by analysts at Needham & Company LLC.
- 7/31/2024 – Penumbra was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating. They now have a $150.00 price target on the stock, down previously from $289.00.
- 7/31/2024 – Penumbra had its price target lowered by analysts at BTIG Research from $232.00 to $187.00. They now have a “buy” rating on the stock.
- 7/31/2024 – Penumbra had its “buy” rating reaffirmed by analysts at Truist Financial Co.. They now have a $200.00 price target on the stock, down previously from $230.00.
- 7/31/2024 – Penumbra had its price target lowered by analysts at Canaccord Genuity Group Inc. from $272.00 to $176.00. They now have a “buy” rating on the stock.
- 7/16/2024 – Penumbra had its price target lowered by analysts at Truist Financial Co. from $280.00 to $230.00. They now have a “buy” rating on the stock.
- 7/15/2024 – Penumbra had its price target lowered by analysts at Morgan Stanley from $235.00 to $210.00. They now have an “equal weight” rating on the stock.
- 7/15/2024 – Penumbra had its price target lowered by analysts at BTIG Research from $265.00 to $232.00. They now have a “buy” rating on the stock.
- 7/10/2024 – Penumbra had its price target lowered by analysts at Citigroup Inc. from $300.00 to $265.00. They now have a “buy” rating on the stock.
Penumbra Stock Up 0.9 %
NYSE PEN traded up $1.48 during mid-day trading on Friday, reaching $172.73. 131,568 shares of the company’s stock traded hands, compared to its average volume of 367,654. Penumbra, Inc. has a 1-year low of $148.00 and a 1-year high of $302.00. The company has a fifty day simple moving average of $184.57 and a 200-day simple moving average of $215.18. The company has a current ratio of 6.12, a quick ratio of 3.51 and a debt-to-equity ratio of 0.02. The company has a market cap of $6.71 billion, a price-to-earnings ratio of 72.88, a P/E/G ratio of 1.69 and a beta of 0.55.
Penumbra (NYSE:PEN – Get Free Report) last released its earnings results on Tuesday, July 30th. The company reported $0.64 EPS for the quarter, topping analysts’ consensus estimates of $0.56 by $0.08. Penumbra had a return on equity of 8.39% and a net margin of 1.26%. The company had revenue of $299.40 million for the quarter, compared to the consensus estimate of $298.24 million. During the same quarter last year, the business posted $0.43 EPS. Penumbra’s quarterly revenue was up 14.5% compared to the same quarter last year. As a group, equities research analysts expect that Penumbra, Inc. will post 2.88 EPS for the current year.
Insider Buying and Selling
Hedge Funds Weigh In On Penumbra
Several hedge funds have recently modified their holdings of the company. Dimensional Fund Advisors LP grew its holdings in shares of Penumbra by 7.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 118,828 shares of the company’s stock worth $29,893,000 after acquiring an additional 8,122 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of Penumbra by 0.9% in the 1st quarter. Vanguard Group Inc. now owns 3,690,660 shares of the company’s stock worth $823,681,000 after acquiring an additional 32,557 shares during the last quarter. Quadrant Capital Group LLC grew its holdings in shares of Penumbra by 31.3% in the 4th quarter. Quadrant Capital Group LLC now owns 722 shares of the company’s stock worth $182,000 after acquiring an additional 172 shares during the last quarter. Jennison Associates LLC acquired a new position in shares of Penumbra in the 4th quarter worth $7,503,000. Finally, Allspring Global Investments Holdings LLC grew its holdings in shares of Penumbra by 19.3% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 265,155 shares of the company’s stock worth $66,697,000 after acquiring an additional 42,876 shares during the last quarter. 88.88% of the stock is currently owned by institutional investors and hedge funds.
Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.
Featured Stories
- Five stocks we like better than Penumbra
- Quiet Period Expirations Explained
- Amazon Stock is Primed to Rebound Strongly After AI Bubble Bursts
- What Are the FAANG Stocks and Are They Good Investments?
- Shell Stock: Oil & Gas Giant Committed to Buybacks and Dividends
- Dividend Payout Ratio Calculator
- Chevron Stock Dips as Earnings Miss Highlights Merger Uncertainty
Receive News & Ratings for Penumbra Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Penumbra Inc and related companies with MarketBeat.com's FREE daily email newsletter.